0001333277-18-000039.txt : 20180831
0001333277-18-000039.hdr.sgml : 20180831
20180831192400
ACCESSION NUMBER: 0001333277-18-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180829
FILED AS OF DATE: 20180831
DATE AS OF CHANGE: 20180831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menold Daniel
CENTRAL INDEX KEY: 0001705745
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 181050950
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7999 GATEWAY BLVD., SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-08-29
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001705745
Menold Daniel
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
Vice President, Finance
Common Stock
2018-08-29
4
M
0
5000
5.00
A
5000
D
Common Stock
2018-08-29
4
S
0
5000
13.00
D
0
D
Employee Stock Option (right to buy)
5.00
2018-08-29
4
M
0
5000
0
D
2024-01-21
Common Stock
5000
14459
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The option vested as to 1/4 of the shares on January 22, 2015 and 1/36 per month thereafter.
/s/ Daniel Menold
2018-08-31